Making Science Group, S.A.
MSE:MAKS.MC
9 (EUR) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
2023 Q4 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q2 | 2021 Q2 | 2020 Q4 | 2020 Q2 | |
---|---|---|---|---|---|---|---|---|
Revenue
| 121.857 | 113.909 | 58.021 | 112.531 | 97.601 | 45.598 | 34.442 | 23.229 |
Cost of Revenue
| 102.755 | 108.532 | 53.108 | 105.715 | 90.032 | 39.861 | 32.049 | 21.77 |
Gross Profit
| 19.102 | 5.377 | 4.913 | 6.817 | 7.569 | 5.737 | 2.393 | 1.458 |
Gross Profit Ratio
| 0.157 | 0.047 | 0.085 | 0.061 | 0.078 | 0.126 | 0.069 | 0.063 |
Reseach & Development Expenses
| 0 | 0 | 0.229 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 7.858 | 7.438 | 3.719 | 7.265 | 7.542 | 2.799 | 1.507 | -0.04 |
Other Expenses
| 0.208 | -0.214 | 2.147 | 0.167 | 0.205 | -1.424 | 0.344 | -0.228 |
Operating Expenses
| 7.65 | 7.652 | 6.095 | 7.098 | 7.336 | 4.223 | 1.163 | 0.188 |
Operating Income
| 11.452 | -2.275 | -1.182 | -0.281 | 0.233 | 1.514 | 1.23 | 1.27 |
Operating Income Ratio
| 0.094 | -0.02 | -0.02 | -0.002 | 0.002 | 0.033 | 0.036 | 0.055 |
Total Other Income Expenses Net
| -9.719 | -2.049 | -0.977 | -1.727 | -1.268 | -1.514 | -0.365 | -0.062 |
Income Before Tax
| 1.733 | -4.325 | -2.159 | -2.008 | -1.035 | 0 | 0.866 | 1.208 |
Income Before Tax Ratio
| 0.014 | -0.038 | -0.037 | -0.018 | -0.011 | 0 | 0.025 | 0.052 |
Income Tax Expense
| 1.033 | 0.199 | 0.1 | 1.35 | 0.169 | 0 | 0.273 | 0.259 |
Net Income
| 0.749 | -4.55 | -2.275 | -3.467 | -1.518 | 0 | 0.593 | 0.949 |
Net Income Ratio
| 0.006 | -0.04 | -0.039 | -0.031 | -0.016 | 0 | 0.017 | 0.041 |
EPS
| 0.09 | -0.55 | -0.27 | -0.42 | -0.17 | 0 | 0.086 | 0.14 |
EPS Diluted
| 0.09 | -0.55 | -0.27 | -0.42 | -0.17 | 0 | 0.086 | 0.14 |
EBITDA
| 11.986 | 1.983 | 0.337 | 3.841 | 3.696 | 1.514 | 1.745 | 1.639 |
EBITDA Ratio
| 0.098 | 0.017 | 0.006 | 0.034 | 0.038 | 0.033 | 0.051 | 0.071 |